Key result
Maternal administration of diclofenac in the third trimester was associated with fetal ductus arteriosus constriction, which resulted in an excellent neonatal outcome following immediate caesarean section.
Why the study?
Does maternal diclofenac use in the third trimester cause fetal ductus arteriosus constriction?
Case Report (n=1)
No
Does maternal diclofenac use in the third trimester cause fetal ductus arteriosus constriction?
This case highlights the risk of premature fetal ductus arteriosus constriction following maternal NSAID (diclofenac) use in the third trimester, emphasizing the need for fetal echocardiography and prompt delivery if complications arise.
No takes yet. Share an insight, caveat, or question.
Third-trimester diclofenac warrants fetal monitoring for ductal constriction; single case leaves optimal management strategies open.
Aker et al. (2015) conducted a case report in Prenatal constriction of the ductus arteriosus (n=1). Diclofenac was evaluated on Fetal ductus arteriosus constriction, ascites, and tricuspid regurgitation. Maternal administration of diclofenac in the third trimester was associated with fetal ductus arteriosus constriction, which resulted in an excellent neonatal outcome following immediate caesarean section.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: